$2.50
At close: Jan 22, 8:00 AM EDT
$2.56
0.062.20%
After Hours: Jan 22, 8:00 AM EDT
Comments
Loading...
PD-RX Pharmaceuticals Analyst Ratings and Price Targets | OTC:PDRX | Benzinga
PD-RX Pharmaceuticals Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for PD-RX Pharmaceuticals Corp from these most-recent analyst ratings.
Analyst Ratings for PD-RX Pharmaceuticals
Data brought to you by Benzinga APIs
FAQ
What is the target price for PD-RX Pharmaceuticals (PDRX) stock?
There is no price target for PD-RX Pharmaceuticals
What is the most recent analyst rating for PD-RX Pharmaceuticals (PDRX)?
There is no analyst for PD-RX Pharmaceuticals
When was the last upgrade for PD-RX Pharmaceuticals (PDRX)?
There is no last upgrade for PD-RX Pharmaceuticals
When was the last downgrade for PD-RX Pharmaceuticals (PDRX)?
There is no last downgrade for PD-RX Pharmaceuticals.
When is the next analyst rating going to be posted or updated for PD-RX Pharmaceuticals (PDRX)?
There is no next analyst rating for PD-RX Pharmaceuticals.
Is the Analyst Rating PD-RX Pharmaceuticals (PDRX) correct?
There is no next analyst rating for PD-RX Pharmaceuticals.
Browse analyst ratings and price targets on all stocks.